Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xuezhen Luo
Observed name:
Xuezhen Luo (19275614)
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Obstetrics and Gynecology Hospital of Fudan University
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Obstetrics and Gynecology Hospital of Fudan University
ORCID:
0000-0003-2967-7034
Observed ORCID:
0000-0003-2967-7034
OpenAlex ID:
A5090079647
Hyperinsulinemia is associated with endometrial hyperplasia and disordered proliferative endometrium: A prospective cross-sectional study
2014
·
Weiwei Shan
, Chengcheng Ning
, et al.
·
Gynecologic Oncology
·
66
Conservative management of grade 2 stage IA endometrial carcinoma and literature review
2021
·
Weiwei Shan
, Pengfei Wu
, et al.
·
Journal of obstetrics and gynaecology research
·
20
Estrogen and high-fat diet induced alterations in C57BL/6 mice endometrial transcriptome profile
2017
·
Yali Cheng
, Qiaoying Lv
, et al.
·
Endocrine Connections
·
20
PDF
Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2024
·
Qiaoying Lv
, Tong Su
, et al.
·
Cancer Immunology Research
·
18
Effects of Weight Status and Related Metabolic Disorders on Fertility-Sparing Treatment Outcomes in Endometrial Atypical Hyperplasia and Endometrial Cancer: A Retrospective Study
2022
·
Sijia Liu
, Lulu Wang
, et al.
·
Cancers
·
11
PDF
Proteomic Identification of IL4I1 as a Therapeutic Target in P53-Mutant Endometrial Cancer
2025
·
Hu Li
, Ruonan Zhang
, et al.
·
Cancers
·
1
Temporal Alignment of Funding and Survivor Prevalence in a National Institutes of Health Cancer Survivorship Analysis (Letter-to-the-Editor)
2026
·
Siqi Wu
, Jinyu Zhang
, et al.
·
American Journal of Obstetrics and Gynecology
Supplementary Figure S6 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2026
·
Qiaoying Lv
, Tong Su
, et al.
Supplementary Figure S3 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2026
·
Qiaoying Lv
, Tong Su
, et al.
Supplementary Figure S4 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2026
·
Qiaoying Lv
, Tong Su
, et al.
Supplementary Figure S5 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2026
·
Qiaoying Lv
, Tong Su
, et al.
Supplementary Figure S2 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2026
·
Qiaoying Lv
, Tong Su
, et al.
Supplementary Figure S7 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2026
·
Qiaoying Lv
, Tong Su
, et al.
Supplementary Figure S1 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2026
·
Qiaoying Lv
, Tong Su
, et al.
Effects of dyslipidemia on fertility-sparing treatment outcomes in endometrial atypical hyperplasia and endometrial cancer: a large cohort study
2026
·
Shuhan Luo
, Manrong Wang
, et al.
·
Scientific Reports
PDF
Case Report: Spontaneous pregnancy after fertility-preserving treatment in a patient with low-grade endometrial stromal sarcoma and literature review
2025
·
Manrong Wang
, Pengfei Wu
, et al.
·
Frontiers in Oncology
PDF
Supplementary Materials File S1 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2024
·
Qiaoying Lv
, Tong Su
, et al.
Supplementary Figure S3 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2024
·
Qiaoying Lv
, Tong Su
, et al.
Data from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2024
·
Qiaoying Lv
, Tong Su
, et al.
Data from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2024
·
Qiaoying Lv
, Tong Su
, et al.
Supplementary Figure S6 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2024
·
Qiaoying Lv
, Tong Su
, et al.
Supplementary Figure S7 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2024
·
Qiaoying Lv
, Tong Su
, et al.
Supplementary Tables S1-S6 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2024
·
Qiaoying Lv
, Tong Su
, et al.
Supplementary Figure S5 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2024
·
Qiaoying Lv
, Tong Su
, et al.
Supplementary Figure S1 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
2024
·
Qiaoying Lv
, Tong Su
, et al.
Show more works
View as search
Works count:
29
Citation count:
136
H-index:
5
I10-index:
5
Year
Topic
Type